Defining target volumes for non-small cell lung carcinoma

Seminars in Radiation Oncology

Volumn 14, Issue 4, 2004, Pages 308-314

  Senan, Suresh ^a   Chapet, Olivier ^b   Lagerwaard, Frank J ^a   Ten Haken, Randall K ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

conformal radiotherapy; lung cancer; target volumes

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; RADIOISOTOPE;

ACCURACY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DISEASE COURSE; ELECTIVE SURGERY; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MATHEMATICAL COMPUTING; MEDIASTINUM METASTASIS; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; STATISTICAL SIGNIFICANCE; TECHNIQUE; TOXICITY; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR VOLUME;

EID: 8844244110     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2004.07.004     Document Type: Article

References (83)

1. F.J. Lagerwaard, S. Senan, J.P. van Meerbeeck Has 3D conformal radiotherapy improved the local control in stage I non-small cell lung carcinoma? Radiother Oncol 63 2002 151 157
2. J.A. Hayman, M.K. Martel, R.K. Ten Haken Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy update of a phase I trial J Clin Oncol 19 2001 127 136
3. M.I. Saunders, S. Dische, A. Barrett Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer a randomised multicenter trial Lancet 350 1997 161 165
4. C. Schaake-Koning, W. Van den Bogaert, O. Dalesio Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer N Engl J Med 326 1992 524 530
5. K. Furuse, M. Fukuoka, M. Kawahara Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small cell lung cancer J Clin Oncol 17 1999 2692 2699
6. W.J. Curran, C.B. Scott, C.J. Langer Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III NSCLC RTOG 9410 Proc Am Soc Clin Oncol 22 2003 621
7. J.G. Rosenman, J.S. Halle, M.A. Socinski High-dose conformal radiotherapy for treatment of stage IIIA/B non-small-cell lung cancer technical issues and results of a phase I/II trial Int J Radiat Oncol Biol Phys 54 2002 348 356
8. International Commission on Radiation Units and Measurements Prescribing, Recording, and reporting photon beam therapy 1993 ICRU Bethesda, MD Report 50
9. International Commission on Radiation Units, Measurements Prescribing, recording and reporting photon beam therapy (supplement to ICRU Report 50) 1999 ICRU Bethesda, MD
10. K. Yamada, T. Soejima, T. Minami Three-dimensional treatment planning using electrocardiographically gated multi-detector row CT Int J Radiat Oncol Biol Phys 56 2003 235 239
11. J.R. van Sörnsen de Koste, F.J. Lagerwaard, H.C.J. de Boer Are multiple CT scans required for planning curative radiotherapy in lung tumors of the lower lobe? Int J Radiat Oncol Phys 55 2003 1394 1399
12. T. Craig, J. Battista, V. Moiseenko Considerations for the implementation of target volume protocols in radiation therapy Int J Radiat Oncol Biol Phys 49 2001 241 250
13. J.C. Stroom, H.C. de Boer, H. Huizenga Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability Int J Radiat Oncol Biol Phys 43 1999 905 919
14. M. Van Herk, P. Remeijer, C. Rasch The probability of correct target dosage dose-population histograms for deriving treatment margins in radiotherapy Int J Radiat Oncol Biol Phys 47 2000 1121 1135
15. E. Weiss, C.F. Hess The impact of gross tumor volume (GTV) and clinical target volume (CTV) definition on the total accuracy in radiotherapy theoretical aspects and practical experiences Strahlenther Onkol 179 2003 21 30
16. S. Senan, J.R. van Sörnsen de Koste, M.J. Samson Evaluation of a target contouring protocol for 3-D conformal radiotherapy in non-small cell lung cancer Radioth Oncol 53 1999 245 253
17. F.J. Lagerwaard, P.J.M. van de Vaart, P.W.J. Voet Can errors in reconstructing pre-chemotherapy target volumes contribute to the inferiority of sequential chemoradiation in stage III non-small cell lung cancer? Lung Cancer 38 2002 297 301
18. M. Kara, S.D. Sak, D. Orhan Changing patterns of lung cancer; (3/4 in.) 1.9 cm; still a safe length for bronchial resection margin?. Lung Cancer 30 2000 161 168
19. P. Giraud, M. Antoine, A. Larrouy Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning Int J Radiat Oncol Biol Phys 48 2000 1015 1024
20. K.M. Harris, H. Adams, D.C. Lloyd The effect on apparent size of simulated pulmonary nodules of using three standard CT window settings Clin Radiol 47 1993 241 244
21. P. Giraud Influence of CT images visualization parameters for target volume delineation in lung cancer (abstr) Radiother Oncol 56 suppl 1 2000 39
22. J. Shennib, A. Bogart, J. Herndon Thorascopic wedge resection and radiotherapy for T1N0 non-small cell lung cancer (NSCLC) in high risk patients preliminary analysis of a CALGB and ECOG Phase II Trial Int J Radiat Oncol Biol Phys 48 suppl 1 2000 232
23. R. Chan, Y. He, A. Haque Computed tomographic-pathologic correlation of gross tumor volume and clinical target volume in non-small cell lung cancer a pilot experience Arch Pathol Lab Med 125 2001 1469 1472
24. C.B. Caldwell, K. Mah, Y.C. Ung Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT the impact of 18FDG-hybrid PET fusion Int J Radiat Oncol Biol Phys 51 2001 923 931
25. U. Nestle, K. Walter, S. Schmidt 18F-Deoxyglucose Positron Emission Tomography (FDG-Pet) for the planning of radiotherapy in lung cancer high impact in patients with atelectasis Int J Radiat Oncol Biol Phys 44 1999 593 597
26. S.M. Bakheet, M. Saleem, J. Powe F-18 fluorodeoxyglucose chest uptake in lung inflammation and infection Clin Nucl Med 25 2000 273 278
27. J.R. van Sörnsen de Koste, F.J. Lagerwaard, M.R.J. Nijssen-Visser Tumor location cannot predict the mobility of lung tumors a 3D analysis of data generated from multiple CT scans Int J Radiat Oncol Biol Phys 56 2003 348 354
28. C.W. Stevens, R.F. Munden, K.M. Forster Respiratory-driven lung tumor motion is independent of tumor size, tumor location, and pulmonary function Int J Radiat Oncol Biol Phys 51 2001 62 68
29. K.E. Sixel, M. Ruschin, R. Tirona Digital fluoroscopy to quantify lung tumor motion potential for patient-specific planning target volumes Int J Radiat Oncol Biol Phys 57 2003 717 723
30. J.T. Booth, S.F. Zavgorodni Modelling the dosimetric consequences of organ motion at CT imaging on radiotherapy treatment planning Phys Med Biol 46 2001 1369 1377
31. J.M. Balter, R.K. Ten Haken, T.S. Lawrence Uncertainties in CT-based radiation therapy treatment planning associated with patient breathing Int J Radiat Oncol Biol Phys 36 1996 167 174
32. F.J. Lagerwaard, J.R. van Sornsen de Koste, M.R.J. Nijssen-Visser Multiple 'slow' CT scans for incorporating lung tumor mobility in radiotherapy planning Int J Radiat Oncol Biol Phys 51 2001 932 937
33. J.R. van Sornsen de Koste, F.J. Lagerwaard, R.H. Schuchhard-Schipper Dosimetric consequences of tumor mobility in radiotherapy of stage I non-small cell lung cancer-an analysis of data generated using 'slow' CT scans Radiother Oncol 61 2001 93 99
34. J.R. van Sornsen de Koste, F.J. Lagerwaard, H.C. de Boer Are multiple CT scans required for planning curative radiotherapy in lung tumors of the lower lobe? Int J Radiat Oncol Biol Phys 55 2003 1394 1399
35. H. Onishi, K. Kuriyama, T. Komiyama A new irradiation system for lung cancer combining linear accelerator, computed tomography, patient self-breath-holding, and patient-directed beam-control without respiratory monitoring devices Int J Radiat Oncol Biol Phys 56 2003 14 20
36. Y. Negoro, Y. Nagata, T. Aoki The effectiveness of an immobilization device in conformal radiotherapy for lung tumor reduction of respiratory tumor movement and evaluation of the daily setup accuracy Int J Radiat Oncol Biol Phys 50 2001 889 898
37. H. Hof, K.K. Herfarth, M. Munter Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC) Int J Radiat Oncol Biol Phys 56 2003 335 341
38. J. Hanley, M.M. Debois, D. Mah Deep inspiration breath-hold technique for lung tumors the potential value of target immobilization and reduced lung density in dose escalation Int J Radiat Oncol Biol Phys 45 1999 603 611
39. J.W. Wong, M.B. Sharpe, D.A. Jaffray The use of active breathing control (ABC) to reduce margin for breathing motion Int J Radiat Oncol Biol Phys 44 1999 911 919
40. R. Hara, J. Itami, T. Kondo Stereotactic single high dose irradiation of lung tumors under respiratory gating Radiother Oncol 63 2002 159 163
41. R.I. Whyte, R. Crownover, M.J. Murphy Stereotactic radiosurgery for lung tumors preliminary report of a phase I trial Ann Thorac Surg 75 2003 1097 1101
42. H. Shirato, S. Shimizu, K. Kitamura Four-dimensional treatment planning and fluoroscopic real-time tumor tracking radiotherapy for moving tumor Int J Radiat Oncol Biol Phys 48 2000 435 442
43. S. Shimizu, H. Shirato, S. Ogura Detection of lung tumor movement in real-time tumor-tracking radiotherapy Int J Radiat Oncol Biol Phys 51 2001 304 310
44. P.J. Keall, S. Joshi, G. Tracton 4-Dimensional radiotherapy planning Int J Radiat Oncol Biol Phys 57 2003 233
45. S.S. Vedam, P.J. Keall, V.R. Kini Acquiring a four-dimensional computed tomography dataset using an external respiratory signal Phys Med Biol 48 2003 45 62
46. E.C. Ford, G.S. Mageras, E. Yorke Respiration-correlated spiral CT a method of measuring respiratory-induced anatomic motion for radiation treatment planning Med Phys 30 2003 88 97
47. C.F. Mountain, C.M. Dresler Regional lymph node classification for lung cancer staging Chest 111 1997 1718 1723
48. S. Senan, D. DeRuysscher, P. Giraud Literature-based recommendations for treatment planning and execution for high-precision radiotherapy in lung cancer Radioth Oncol 71 2004 139 146
49. J.R. van Sörnsen de Koste, F.J. Lagerwaard, M.R.J. Nijssen-Visser Which margins are necessary for incorporating mediastinal nodal mobility in involved field radiotherapy for lung cancer? Int J Radiat Oncol Biol Phys 53 2002 115 119
50. K.T. Hujala, J.I. Sipila, R. Grenman Mediastinoscopy--its role and value today in the differential diagnosis of mediastinal pathology Acta Oncol 40 2001 79 82
51. M. Coughlin, J. Deslauriers, M. Beaulieu Role of mediastinoscopy in pretreatment staging of patients with primary lung cancer Ann Thorac Surg 40 1985 556 560
52. A. Fritscher-Ravens Endoscopic ultrasound evaluation in the diagnosis and staging of lung cancer Lung Cancer 41 2003 259 267
53. A. Fritscher-Ravens, K.H. Bohuslavizki, L. Brandt Mediastinal lymph node involvement in potentially resectable lung cancer comparison of CT, positron emission tomography, and endoscopic ultrasonography with and without fine-needle aspiration Chest 123 2003 442 451
54. J.K. LeBlanc, R. Espada, G. Ergun Non-small cell lung cancer staging techniques and endoscopic ultrasound tissue is still the issue Chest 123 2003 1718 1725
55. P.N. Cascade, B.H. Gross, E.A. Kazbraoni Variability in the detection of enlarged mediastinal lymph nodes in staging lung cancer a comparison of contrast-enhanced and unenhanced CT Am J Radiol 170 1998 927 931
56. E.F. Patz Jr, J.J. Erasmus, H.P. McAdams Lung cancer staging and management comparison of contrast-enhanced and non-enhanced helical CT of the thorax Radiology 212 1999 56 60
57. G.M. Glazer, B.H. Gross, L.E. Quint Normal mediastinal lymph nodes number and size according to American Thoracic Society mapping AJR Am J Roentgenol 144 1985 261 265
58. K. Kiyono, S. Sone, F. Sakai The number and size of normal mediastinal lymph nodes a postmortem study AJR Am J Roentgenol 150 1988 771 776
59. K.L. Prenzel, S.P. Monig, J.M. Sinning Lymph node size and metastatic infiltration in non-small cell lung cancer Chest 123 2003 463 467
60. T. Arita, T. Matsumoto, T. Kuramitsu Is it possible to differentiate malignant mediastinal nodes from benign nodes by size? Reevaluation by CT, transesophageal echocardiography, and nodal specimen. Chest 110 1996 1004 1008
61. B.A. Dwamena, S.S. Sonnad, J.O. Angobaldo Metastases from non small cell lung carcinoma: mediastinal staging in the 1990's. Meta-analytic comparison of PET and CT Radiology 213 1999 530 536
62. J.F. Vansteenkiste, S.G. Stroobants, P.R. De Leyn Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer a prospective analysis of 50 cases Chest 112 1997 1480 1486
63. N.C. Gupta, G.M. Graeber, H.A. Bishop Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions Chest 117 2000 773 778
64. P.F. Roberts, D.M. Follette, D. von Haag Factors associated with false-positive staging of lung cancer by positron emission tomography Ann Thorac Surg 70 2000 1154 1159
65. L.J. Vanuytsel, J.F. Vansteenkiste, S.G. Stroobants The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer Radiother Oncol 55 2000 317 324
66. M.M. Osman, C. Cohade, Y. Nakamoto Clinically significant inaccurate localization of lesions with PET/CT frequency in 300 patients J Nucl Med 44 2003 240 243
67. J.F. Vansteenkiste, S.G. Stroobants, P.R. De Leyn Lymph node staging in non-small-cell lung cancer with FDG-PET scan a prospective study on 690 lymph node stations from 68 patients J Clin Oncol 16 1998 2142 2149
68. D. Lardinois, W. Weder, T.F. Hany Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography N Engl J Med 348 2003 2500 2507
69. B. Emami Three-dimensional conformal radiation therapy in bronchogenic carcinoma Semin Radiat Oncol 6 1996 92 97
70. B. Emami, N. Mirkovic, C. Scott The impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable non-small cell lung cancer an analysis of RTOG data Lung Cancer 41 2003 207 214
71. I.S. Grills, D. Yan, A.A. Martinez Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation Int J Radiat Oncol Biol Phys 57 2003 875 890
72. T. Le Chevalier, R. Arriagada, M. Tarayre Significant effect of adjuvant chemotherapy on survival in locally advanced non-small cell lung carcinoma J Natl Cancer Inst 84 1992 58
73. B.J. Slotman, I.E. Antonisse, K.H. Njo Limited field irradiation in early stage (T1-2N0) non-small cell lung cancer Radiother Oncol 41 1996 41 44
74. A.D. Krol, P. Aussems, E.M. Noordijk Local irradiation alone for peripheral stage I lung cancer could we omit the elective regional nodal irradiation? Int J Radiat Oncol Biol Phys 34 1996 297 302
75. M. Oda, Y. Watanabe, J. Shimizu Extent of mediastinal node metastasis in clinical stage I non-small-cell lung cancer the role of systematic nodal dissection Lung Cancer 22 1998 23 30
76. X. Qiao, O. Tullgren, I. Lax The role of radiotherapy in treatment of stage I non-small cell lung cancer Lung Cancer 41 2003 1 11
77. G.S. Sibley Radiotherapy for patients with medically inoperable stage I non-small cell lung carcinoma smaller volumes and higher doses--a review Cancer 82 1998 433 438
78. J.S. Belderbos, K. De Jaeger, W.D. Heemsbergen First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy Radiother Oncol 66 2003 119 126
79. S. Senan, J.A. Burgers, M.J. Samson Can elective nodal irradiation be omitted in stage III non-small cell lung cancer? An analysis of recurrences in a phase II study of induction chemotherapy and 'involved-field' radiotherapy Int J Radiat Oncol Biol Phys 54 2002 999 1006
80. K.E. Rosenzweig, S.E. Sim, B. Mychalczak Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy Int J Radiat Oncol Biol Phys 50 2001 681 685
81. V.W. Rusch, D.J. Giroux, M.J. Kraut Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160) J Thorac Cardiovasc Surg 121 2001 472 483
82. M. Tsuboi, H. Kunitoh, H. Kato A phase II trial of pre-operative chemoradiotherapy followed by surgery in Pancoast tumors initial report of Japan Clinical Oncology Group trial (JCOG 9806) (abstr) Lung Cancer 41 2003 78
83. H.C. De Boer, J.R. van Sornsen de Koste, S. Senan Analysis and reduction of 3D systematic and random setup errors during the simulation and treatment of lung cancer patients with CT-based dose planning Int J Radiat Oncol Biol Phys 49 2001 857 868